09/15/2026
How can we make advanced therapies more accessible to patients around the world – not just for those in countries with the resources to support them?
In the latest episode of Commercializing Living Therapies with CCRM, host Krista Lamb is joined by Bambi Grilley, Baylor College of Medicine, and Staci Arnold, Emory University and Children's Healthcare of Atlanta, to explore the challenges and opportunities involved in the equitable deployment of cell and gene therapies (CGTs).
They cover:
🔹 The current landscape of CGT access in low- and middle-income countries
🔹 Economic, manufacturing, delivery and regulatory barriers
🔹 The potential of public-private partnerships and other access models
🔹 The role of patients and health NGOs
🔹 Why equitable access is particularly important in cancer care
🔹 What is giving experts hope for the future
As CGTs become increasingly available, ensuring that these therapies reach patients globally will require collaboration, innovation and new approaches to access.
Listen at the link below, or find it wherever you stream podcasts.
https://www.ccrm.ca/podcast/
